Overactive Bladder - Results from #2240

How does the urothelium affect bladder function in health and disease? - Abstract February 24, 2012

Physiopathology of overactive bladder syndrome - Abstract February 21, 2012

Long-term safety, tolerability and efficacy of fesoterodine in subjects with overactive bladder symptoms stratified by age: Pooled analysis of two open-label extension studies - Abstract February 7, 2012

Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients - Abstract February 7, 2012

Defining urinary urgency: Patient descriptions of "gotta go" - Abstract February 6, 2012

The effect of rectal distension on bladder function in patients with overactive bladder - Abstract February 3, 2012

The prevalence and therapeutic effect of constipation in pediatric overactive bladder - Abstract January 31, 2012

Which anticholinergic drug for overactive bladder symptoms in adults - Abstract January 30, 2012

Spanish cultural adaptation and psychometrical validation of the Treatment Benefit Scale (TBS) in the symptomatic treatment of overactive bladder - Abstract January 27, 2012

The assessment of quality of life in female Turkish patients with overactive bladder - Abstract January 26, 2012

Overactive bladder syndrome: The social and economic perspective - Abstract January 23, 2012

Muscarinic agonists and antagonists: Effects on the urinary bladder - Abstract January 20, 2012

Role of potassium ion channels in detrusor smooth muscle function and dysfunction January 19, 2012

The influence of melatonin and agomelatine on urodynamic parameters in experimental overactive bladder model - preliminary results January 19, 2012

Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity - Abstract January 19, 2012

Behaviour change to treat overactive bladder syndrome - Abstract January 18, 2012

Repeated botulinum toxin type A injections for refractory overactive bladder: Medium-term outcomes, safety profile, and discontinuation rates - Abstract January 17, 2012

Effects and mechanisms of phosphodiesterase type 5 inhibitors on rats with overactive bladder January 12, 2012

Overactive bladder: Diagnosis and management - Abstract January 9, 2012

Prescription pattern of oxybutynin ER in patients with overactive bladder in real life practice: A multicentre, open-label, prospective observational study - Abstract January 6, 2012

Page 113 of 122